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Background. Elevated plasma levels of interleukin (IL)-6, C-reactive protein (CRP), and D-dimer belong to the
biological alterations of the ‘‘frailty syndrome,’’ defining increased vulnerability for diseases and mortality with aging. We
hypothesized that, compatible with premature frailty, chronic stress and age are related in predicting inflammation and
coagulation activity in Alzheimer caregivers.
Methods. Plasma IL-6, CRP, and D-dimer levels were measured in 170 individuals (mean age 73 6 9 years; 116
caregivers, 54 noncaregiving controls). Demographic factors, diseases, drugs, and lifestyle variables potentially affecting
inflammation and coagulation were obtained by history and adjusted for as covariates in statistical analyses.
Results. Caregivers had higher mean levels of IL-6 (1.38 6 1.42 vs 1.00 6 0.92 pg/mL, p ¼ .032) and of D-dimer
(723 6 530 vs 471 6 211 ng/mL, p , .001) than controls had. CRP levels were similar between groups (p¼ .44). The
relationship between caregiver status and D-dimer was independent of covariates (p¼ .037) but affected by role overload.
Age accounted for much of the relationship with IL-6. After controlling for covariates, the interaction between caregiver
status and age was significant for D-dimer (b¼ .20, p¼ .029) and of borderline significance for IL-6 (b¼ .17, p¼ .090).
Post hoc regression analyses indicated that, among caregivers, age was significantly correlated with both D-dimer (b¼ .50,
p , .001) and IL-6 (b¼ .38, p¼ .001). Among controls, however, no significant relationship was observed between age
and either D-dimer or IL-6.
Conclusions. The interaction between caregiving status and age for D-dimer and IL-6 suggests the possibility that
older caregivers could be at risk of a more rapid transition to the frailty syndrome and clinical manifestations of
cardiovascular diseases.
PROVIDING care to a spouse who is suffering fromAlzheimer’s disease confers a significant health risk
(1). Dementia caregivers have higher rates of hypertension
(2) and coronary artery disease (CAD) (3), and they also
show slower wound healing (4) than do people in the com-
munity who are not caregivers. Moreover, all-cause mor-
tality is higher in caregivers than in controls (5). Increased
morbidity and premature death in caregivers suggest that
caregiving strain could hasten the transition to the ‘‘frailty
syndrome’’ that is linked to a range of physiological altera-
tions which arise during the process of aging (6).
Frailty designates a decline in health function that is
accompanied by an increase in disease vulnerability and
mortality (7). The proinflammatory cytokine interleukin
(IL)-6, the acute phase reactant C-reactive protein (CRP),
and the procoagulant molecule D-dimer all increase with
age, and elevated plasma levels of these three measures
have also been identified as biological accompaniments of
frailty (8,9). Whereas the pleiotropic biological activity of
IL-6 highlights its role in many different diseases of older
age (10), activities of CRP and D-dimer are more intimately
related to CAD (11,12).
There is a strong interplay between inflammation and
coagulation in arterial vascular pathology (13). Population
studies found associations between IL-6 and D-dimer (14)
and between CRP and D-dimer (14,15). On a mechanistic
level, IL-6 stimulates hepatic synthesis of CRP (16) and D-
dimer stimulates monocytes to produce IL-6 in vitro (17).
A recent review of data from the Cardiovascular Health
Study (18) concluded that IL-6, CRP, and D-dimer might
play a particularly important role in atherosclerosis devel-
opment in elderly persons (19–21).
Women who are Alzheimer caregivers have higher levels
of IL-6 than do noncaregiving control women (22), and
caregiving strain has been prospectively associated with an
increase in plasma IL-6 levels in Alzheimer caregivers of
both sexes (23). In a preliminary study on a subset of indi-
viduals investigated in the present study, we reported higher
D-dimer in caregivers than in gender-matched controls (24).
Therefore, low-grade systemic inflammation and coagula-
tion activation in response to caregiving strain provides one
biological pathway through which caregivers might age
more rapidly and as a consequence manifest, for example,
cardiovascular disease (2,3) at a younger age than non-
caregivers might. It is unknown, however, whether the
burden of caregiving and increased age are related in pre-
dicting the level of systemic inflammatory and coagulant
processes. Their being related would imply that caregiver
stress and age interact in accelerating the transition to the
frailty syndrome. Although cross-sectional, such an obser-
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vation might inspire prospective research to possibly
confirm the hypothesis that markers of frailty predict
cardiovascular morbidity and mortality in dementia care-
givers several years down the line.
We compared IL-6, CRP, and D-dimer in 116 Alzheimer
caregivers and 54 noncaregiving controls and controlled for
demographic factors, diseases, drugs, and lifestyle variables
known to affect inflammation and coagulation. We also as-
sessed levels of general psychological distress, role overload,
and social support to confirm our a priori assumption that
caregivers are more stressed than are controls. Our first aim
was to confirm previous findings of increased IL-6 (22) and
D-dimer (24) in caregivers. We further hypothesized that
CRP would be higher in caregivers than in controls. Our
second aim was to investigate the role of age in the relation-
ship between caregiving strain and frailty indices. We hypoth-
esized that age would mediate the relationships between
caregiving strain and frailty markers or that age would in-
teract with caregiver status in predicting frailty markers.
METHODS
Participants
Venous blood to measure D-dimer, IL-6, and CRP was
obtained from 170 participants (116 caregivers, 54 controls;
51 men, 119 women; 93% Caucasian) who participated in
a longitudinal study on effects of dementia caregiving stress
on health. We report cross-sectional data obtained after
completion of the study’s enrollment period. All participants
were recruited from the University of California at San
Diego (UCSD) Research Centers, through community sup-
port groups or through physician referrals. They gave written
informed consent to the study protocol, which was approved
by the UCSD Institutional Review Board. All caregivers
were spouses of patients with Alzheimer’s disease who lived
with and provided informal in-home care for the patient. The
control group consisted of community-dwelling elderly men
and women not providing care to a household member but
also living with their spouse. Controls were recruited in the
same proportion of gender as caregivers through a variety of
means including community outreach, advertising, referrals
from study participants and the community, and collabo-
rations with the UCSD Alzheimer Disease Research Center.
Controls were not excluded for stressful life events or any
other reasons in order that a representative sample of non-
caregivers could be studied. All participants had to be  55
years old and free of anticoagulant medication.
Medical Data
At participants’ homes, a research nurse conducted
a structured medical history that asked about past and
present diagnoses of diseases and treatment including any
medications as well as health habits. Here, we specifically
report on health characteristics, which may affect inflamma-
tion and coagulation. Smoking status was specified in terms
of never smokers, former smokers, and current smokers with
the latter group also indicating the average number of
cigarettes currently smoked per day. However, only 6%
of participants (7 caregivers and 3 controls) were current
smokers. The proportion of current smokers (p ¼ .92) and
the number of cigarettes currently smoked daily (caregivers
1.0 6 4.8, controls 0.1 6 0.6; p ¼ .81) were not different
between groups. Therefore, the number of cigarettes smoked
per day was not used for further analyses, and smokers were
categorized into current or former smokers (n ¼ 78) and
never smokers (n¼86). Alcohol consumption was quantified
in terms of the number of drinks of alcohol that participants
consumed in an average week during the last 6 months.
Physical exercise was quantified in terms of the number of
days participants performed physical exercise in an average
week during the last 6 months. Medical data were complete
for all 170 caregivers and controls except for reports on
smoking status (n ¼ 164), alcohol consumption (n ¼ 157),
and physical exercise (n¼ 158).
Body mass index (BMI) was computed as the ratio
between weight in kilograms and height in square meters.
For statistical analyses, cancer was defined as a positive
history of any current or lifetime cancer diagnosis. Cere-
brovascular disease was defined as a positive history for
stroke or transient ischemic attack. CAD was considered
positive if there was a history of myocardial infarction,
angina, heart attack, or coronary artery bypass surgery.
Platelet aggregation–inhibiting medication consisted of
aspirin, various types of nonsteroidal anti-inflammatory
drugs, ticlopidine, or clopidrogel. The different sorts of
antihypertensives (e.g., diuretics, calcium channel blockers),
statins, hormone replacements (estrogen replacement or
combined estrogen and progesterone replacement), and anti-
depressants (e.g., selective serotonin reuptake inhibitors,
tricyclics) were grouped in one category each.
Psychosocial Measures
Caregivers and controls were asked to complete a set of
self-rated questionnaires when the nurse visited them at their
homes. We used the Brief Symptom Inventory (BSI) global
severity index to asses the extent to which participants felt
global psychological distress (25). For the BSI, participants
are asked to rate how much each of 53 items ‘‘had caused
distress during the past six months, including today.’’
Response choices range from 0 (not at all) to 4 (extremely).
Average responses to different subscales are used to
calculate an overall score ranging between 0 and 4. Pearlin’s
Role Overload scale (26) was used to assess the extent to
which caregivers and controls felt overwhelmed or over-
loaded by life responsibilities. The scale consists of 4 items
rated from 1 (not at all) to 4 (completely); for example, ‘‘you
work hard (as a caregiver) but never seem to make any
progress.’’ The sections in parentheses specific to caregivers
were excluded in the questionnaires given to noncaregiv-
ing controls. The scale has demonstrated good internal re-
liability (Cronbach’s alpha ¼ .80). For the present study,
average responses to each item were used to create an
overall overload score (range, 1–4). Perceived social support
was measured by Pearlin’s Expressive Support Scale (26)
asking eight questions (Cronbach’s alpha ¼ .87) with
responses ranging from 1 (strongly disagree) to 4 (strongly
agree) providing an average support score (range, 1–4).
Twelve participants had missing data for BSI global sever-
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ity index, whereas data on role overload and on social sup-
port were complete in all participants.
Biological Assays
At each participant’s home, venous blood was drawn
through a 22-gauge venous forearm catheter. Blood for the
D-dimer assay was dispensed into polypropylene tubes
containing 3.8% sodium citrate (9:1, vol/vol) and spun at
2000 g for 10 minutes at room temperature. Blood for the IL-
6 and CRP assays was dispensed in EDTA tubes and spun
at 3000 g for 10 minutes at 4–88C. Obtained plasma was
immediately stored in plastic tubes at808C until analyzed.
Plasma D-dimer levels were measured by an enzyme-
linked immunosorbent assay (Asserachrom Stago, Asnie`res,
France). Plasma levels of IL-6 were measured by a high-
sensitivity immunoassay kit (Quantikine, R&D Systems,
Minneapolis, MN). Measurement of plasma CRP levels was
taken by using the High Sensitive CRP Reagent Set
(DiaSorin, Stillwater, MN) using the Roche Cobas Mira
Plus analyzer (Roche, Palo Alto, CA). Intra- and inter-assay
coefficients of variation were ,10% for all analyses.
Because of occasional assay problems, data were missing
for IL-6 in 6 participants (5 caregivers, 1 control), for CRP
in 11 participants (9 caregivers, 2 controls), and for D-dimer
in 8 participants (6 caregivers, 2 controls).
Statistical Analyses
Data were analyzed using the SPSS statistical software
package (version 13.0; Chicago, IL). All testing was two-
tailed with the significance level set at p , .05. Because of
a skewed distribution, values for BMI, alcohol consumption,
physical exercise, IL-6, CRP, D-dimer, BSI global severity
index, and role overload were all logarithmically transformed
before statistical analyses. After logarithmic transformation,
IL-6, CRP, and D-dimer data showed a normal distribution
(Kolmogorov–Smirnov test) with all values for CRP and IL-
6 being within 3 standard deviations (SD) from the mean and
with the highest D-dimer value being ,3.2 SD from the
mean. Data are presented as mean 6 SD or geometric mean
with 95% confidence interval (CI) or both in the text and
tables, and as log-transformed value in the figure.
Pearson and Spearman correlation coefficients were esti-
mated for continuous and categorical variables, respectively.
To calculate differences in the frequency of categorical
variables between caregivers and controls, we used chi-
square testing applying Pearson’s Test or Fisher’s Exact
Test whenever appropriate. We used analyses of variance
(ANOVA) to test for a difference in continuous measures
(e.g., IL-6, CRP, and D-dimer) between caregivers and
controls and analyses of covariance (ANCOVA) to adjust
these differences for the various health characteristics.
Categorical variables (e.g., use of antihypertensive drugs)
were treated and entered as dummy variables (0¼no, 1¼yes).
In a first step, we adjusted for demographic data, health habits,
cardiovascular risk factors and diseases, and the various
medication types to test whether the relationship between
caregiver status and frailty markers would be independent.
In a second step, we further considered emotional support,
general psychological distress, and levels of role overload
as covariates to investigate whether psychosocial measures
would additionally affect this relationship. Post hoc analyses
were by Fisher’s Least Significant Difference.
We also tested whether caregiver status would interact
with age in predicting frailty markers. For this purpose, we
performed linear regression analyses with frailty markers as
dependent variables and caregiver status, age, the interaction
between caregiver status and age, and covariates as inde-
pendent variables (27). From these analyses, we only report
on interaction terms to prevent redundancy with findings
from ANCOVA. A significant interaction between age and
caregiver status suggests a differential relationship between
age and frailty markers for caregivers and controls. To reduce
problems resulting from multicollinearity, we centered age
values to the mean and defined caregiver status as 1/2
(controls) and þ1/2 (caregivers) (28). Collinearity between
predictors was tested and found to be tolerable in all analyses.
In ANCOVA and regression analyses, we omitted
participants who did not have complete data for all
covariates case-wise (i.e., ‘‘listwise’’ deletion in SPSS).
The 25 participants who did not have complete data in terms
of covariates and both D-dimer and IL-6 were not
significantly different in any frailty marker and participant
characteristics listed in Table 1 from the 145 participants
having a complete data set (statistics not shown).
RESULTS
Participants’ Characteristics
Table 1 presents participants’ characteristics showing
that, on average, caregivers were about 5 years older than
controls. Also, caregivers reported a higher rate of
antihypertensive drug intake and engaged in less physical
exercise than controls. The proportions in other variables
of health habits, diseases, and drug categories were equally
distributed between groups. In terms of psychosocial data,
caregivers showed the expected higher levels in general
Table 1. Characteristics of 170 Study Participants
Health Factor
Caregivers
(N ¼ 116)
Controls
(N ¼ 54) p Value
Age, y 72.9 6 8.7 67.6 6 6.8 ,.001
Female 68% 74% .429
Body mass index, kg/m2 25.4 6 4.3 25.8 6 4.7 .502
Never/current or former smoker 51%/49% 55%/45% .686
Alcohol consumption, drinks/wk 4.25 6 5.77 4.35 6 5.31 .339
Physical exercise, d/wk 2.19 6 2.36 2.98 6 2.46 .033
Hypercholesterolemia 35% 37% .830
Arterial hypertension 35% 21% .142
Type II diabetes 3% 6% .681
Cancer 30% 22% .281
Cerebrovascular disease 3% 0% .308
Coronary artery disease 6% 4% .721
Platelet antiaggregant drug 38% 30% .292
Antihypertensive drug 47% 30% .037
Statin medication 17% 28% .114
Hormone replacement therapy 36% 48% .139
Antidepressant drug 25% 17% .225
General distress 0.46 6 0.42 0.30 6 0.25 ,.001
Role overload 2.30 6 0.81 1.54 6 0.51 ,.001
Social support 1.78 6 0.50 1.67 6 0.43 .172
Note: Data are given as means 6 standard deviation or percentage values.
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psychological distress and role overload compared with
controls, whereas the amount of perceived social support did
not differ between groups.
Association of Coagulation and Inflammation
With Participants’ Characteristics
Table 2 shows the univariate correlation coefficients for
the relationships between IL-6, CRP, and D-dimer and the
various demographic factors and health characteristics in the
entire study population. There were significant bivariate
associations between inflammation and coagulation mea-
sures with age, gender, BMI, several drug categories, and
social support. In contrast, IL-6, CRP, and D-dimer did not
significantly correlate with smoking status, disease history,
general psychological distress, and role overload.
Associations Between Coagulation and
Inflammation Markers
In bivariate correlation analyses, IL-6 correlated with D-
dimer (r¼ .33, p , .001) and with CRP (r¼ .37, p , .001).
In addition, CRP showed a trend towards a statistically
significant correlation with D-dimer (r ¼ .15, p , .07).
Differences in Coagulation and Inflammation
Markers Between Groups
Multivariate ANOVA showed a significant group (care-
giver vs controls) effect (F3,145 ¼ 5.1, p ¼ .002). Table 3
shows that caregivers had higher mean D-dimer levels
(F1,160 ¼ 13.7, p , .001) and higher mean IL-6 levels
(F1,162 ¼ 4.7, p ¼ .032) than controls, whereas mean CRP
levels did not differ between groups (F1.157¼ 0.6, p¼ .436).
We then computed ANCOVA with adjustment for all
demographic and medical health characteristics as cova-
riates (cf. Table 3 legend for detailed list of covariates).
Caregivers continued to have higher D-dimer than controls
(F18,132 ¼ 4.4, p ¼ .037) with age emerging as the only
significant covariate of D-dimer (F1,132 ¼ 21.0, p , .001).
Further adjustment for emotional support (F19,131 ¼ 3.6,
p¼ .059) or general psychological distress (F19,129¼3.5, p¼
.063) essentially maintained the difference in D-dimer
between groups. However, when entering the level of role
overload as a covariate, the difference in D-dimer between
caregivers and controls became insignificant (F19,131 ¼ 1.8,
p¼ .18). These analyses suggest that caregivers had higher
D-dimer levels than controls had because they had greater
role overload, not because they were older than controls.
In contrast, IL-6 levels were no longer different between
groups when controlling for demographic and medical
health characteristics (F18,132¼ 0.4, p¼ .54). In that model,
age (F1,132¼ 9.5, p¼ .003) and BMI (F1,132¼ 7.6, p¼ .007)
both emerged as significant covariates of IL-6, suggesting
that age accounted for a considerable proportion of the
relationship between caregiver status and level of IL-6.
Further adjustment for social support, psychological dis-
tress, and role overload did not yield a significant
association between caregiver status and IL-6 levels. CRP
remained also unchanged between groups after adjustment
for demographic and health characteristics (F18,128 ¼ 0.3,
p ¼ .62); BMI emerged as the only significant covariate of
CRP (F1,128 ¼ 20.1, p , .001). Additional adjustment for
psychosocial variables did not change these findings.
Role of Age
The above analyses showed that caregivers had higher
D-dimer than did controls independent of age; however, the
relationship between caregiver status and IL-6 was elimi-
nated when age was included in the model, suggesting that
age better accounted for elevated IL-6 than caregiver status.
We elected to conduct additional analyses to determine
whether age was differentially associated with D-dimer and
IL-6 for caregivers and controls. For this purpose, we
conducted multiple regression analyses to test for a signif-
icant interaction between caregiver status and age in
Table 2. Correlations Between Health Characteristics and
Coagulation and Inflammation
Health Factor IL-6 CRP D-dimer
Age, y .30* .03 .47*
Gender (male ¼ 0, female ¼ 1) .03 .17y .13
Body mass index, kg/m2 .24z .32* .06
Former or current smoker (no ¼ 0, yes ¼ 1) .06 .09 .09
Alcohol consumption, drinks/wk .08 .03 .10
Physical exercise, d/wk .04 .11 .12
Hypercholesterolemia (no ¼ 0, yes ¼ 1) .04 .15 .05
Arterial hypertension (no ¼ 0, yes ¼ 1) .14 .04 .15
Type II diabetes (no ¼ 0, yes ¼ 1) .01 .03 .01
Cancer (no ¼ 0, yes ¼ 1) .05 .03 .12
Cerebrovascular disease (no ¼ 0, yes ¼ 1) .08 .08 .02
Coronary artery disease (no ¼ 0, yes ¼ 1) .08 .07 .15
Platelet antiaggregant drug (no ¼ 0, yes ¼ 1) .10 .01 .08
Antihypertensive drug (no ¼ 0, yes ¼ 1) .18y .05 .23z
Statin medication (no ¼ 0, yes ¼ 1) .01 .16y .04
Hormone replacement therapy (no ¼ 0, yes ¼ 1) .12 .20y .21z
Antidepressant drug (no ¼ 0, yes ¼ 1) .01 .20y .06
General distress .01 .04 .03
Role overload .03 .05 .07
Social support .09 .01 .16y
Notes: Significance level of correlation coefficients: *p , .001; yp , .05;
zp , .01.
IL-6 ¼ interleukin-6; CRP ¼ C-reactive protein.
Table 3. Frailty Markers in Caregivers and Controls
Frailty
Marker
Analyses of Variance Analyses of Covariance*
Caregivers Controls Caregivers Controls
D-dimer,
ng/mL
723 6 530y 471 6 211 696 6 448z 524 6 464
600 (542–665) 429 (370–497) 571 (515–632) 466 (401–542)
n ¼ 110 n ¼ 52 n ¼ 101 n ¼ 50
IL-6, pg/mL 1.38 6 1.42z 1.00 6 0.92 1.26 6 1.35 1.23 6 1.39
1.00 (0.86–1.15) 0.76 (0.62–0.93) 0.92 (0.80–1.08) 0.85 (0.68–1.06)
n ¼ 111 n ¼ 53 n ¼ 101 n ¼ 50
CRP, mg/L 3.20 6 6.00 2.28 6 2.88 3.73 6 5.53 1.85 6 5.73
1.57 (1.25–1.96) 1.34 (0.97–1.85) 1.52 (1.21–1.93) 1.36 (0.97–1.92)
n ¼ 107 n ¼ 52 n ¼ 97 n ¼ 50
Notes: Data are given as means 6 standard deviation and as geometric
means (95% confidence interval).
*Adjusted for age, gender, body mass index, smoking status, alcohol
consumption, exercise, hypercholesterolemia, hypertension, diabetes, cancer,
cerebrovascular and coronary artery disease, and drugs (platelet inhibiting
medication, antihypertensives, statins, hormone replacement therapy, antide-
pressants).
yp , .001; zp , .05.
IL-6 ¼ interleukin-6; CRP ¼ C-reactive protein.
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predicting levels of D-dimer and IL-6, both with and
without adjustment for medical and psychosocial covariates.
Crude interaction effect.—Results of our first regression
analysis, predicting D-dimer levels, revealed a significant
interaction between age and caregiver status (t ¼ 2.02, p ¼
.045). This interaction indicated that age was differentially
associated with level of D-dimer among caregivers and con-
trols. Post hoc analyses using the method described by
Holmbeck (27) revealed that age was significantly correlated
with D-dimer in caregivers (b ¼ .50, p , .001; n ¼ 110;
Figure 1A), but not in controls (b ¼ .16, p ¼ .31; n ¼ 52;
Figure 1B). Results of our regression analysis predicting
IL-6 levels revealed a nonsignificant interaction between age
and caregiver status (p ¼ .18), suggesting that age was
similarly related with IL-6 in both groups.
Adjustment for covariates.—Gender, BMI, smoking
status, alcohol consumption, exercise, hypercholesterolemia,
hypertension, diabetes, cancer, cerebrovascular disease and
CAD, platelet antiaggregants, antihypertensives, statins,
hormone replacements, and antidepressants were then also
entered into regression equations. For D-dimer, the Age 3
Caregiver status interaction continued to be significant
(t ¼ 2.21, p ¼ .029). Similarly, the interaction remained
significant after additional controlling for emotional support,
general psychological distress, and role overload (t ¼ 2.58,
p¼ .011). Post hoc analyses controlling for all demographic,
medical, and psychosocial measures showed that age was
significantly associated with D-dimer in caregivers (b¼ .50,
p, .001; n¼99), but not in controls (b¼ .03, p¼ .84; n¼50).
The interaction between caregiver status and age was not
a significant predictor of IL-6 level after controlling for the
same set of demographic and medical covariates (p ¼ .14).
When emotional support, psychological distress, and role
overload were also controlled for, however, the Caregiver
status 3 Age interaction reached borderline significance
(t ¼ 1.71, p ¼ .090). To explore this observation further,
post hoc analyses were conducted while controlling for all
demographic, medical, and psychosocial variables. Results of
these analyses indicated that age was positively associated with
IL-6 level among caregivers (b¼ .38, p¼ .001; B¼ .016; n¼
99), but not among controls (b¼ .04, p¼ .81; B¼ .002; n¼50).
DISCUSSION
Confirming previous studies (22,24), crude analyses
showed higher plasma levels of IL-6 and D-dimer in
Alzheimer caregivers compared to noncaregiving controls.
Controlling for various demographic variables (including age)
and health characteristics known to affect IL-6 and D-dimer
(8,9,29–34), levels of D-dimer but not levels of IL-6 continued
to be higher in caregivers than in controls suggesting that
caregiving stress uniquely relates to elevated D-dimer. This
notion gains support from the observation that caregivers had
significantly higher levels of role overload, and controlling for
overload rather specifically rendered the relationship between
caregiver status and elevated D-dimer nonsignificant. In
contrast, general psychological distress did not meaningfully
affect the relationship between caregiving status and D-dimer
level. In other words, a general state of exhaustion due to the
stresses of caregiving (rather than the experience of general
psychological distress) may result in coagulation activity in
dementia caregivers. Furthermore, although social support
appeared to be related to D-dimer level, controlling for social
support did not affect the relationship between caregiving
status and level of D-dimer, likely due to there being no
relationship between caregiving status and social support.
In our previous study that included a subset of 68 in-
dividuals also included in the present study, D-dimer was
higher in caregivers than in controls (24). Our former
analysis was preliminary, however, because of the compar-
atively small sample size, which did not allow us to reliably
control for covariates including age. D-dimer indicates both
fibrin formation following activation of the coagulation
Figure 1. Interaction between age- and log-transformed D-dimer levels in
caregivers (A) and controls (B). The slope of the fit line was steeper in
caregivers (unstandardized coefficient B ¼ .014) than in controls (B ¼ .004).
Note the identical scaling of the x and y axes.
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cascade and subsequent fibrin degradation by the fibrinoly-
tic system (35). The present findings strongly support our
previous notion that fibrin turnover is exaggerated in
caregivers. The observation that chronic stress of providing
care to a demented spouse confers an increased hypercoag-
ulability risk adds to previous research showing that different
types of chronic stressors elicit D-dimer elevation (36).
As was not the case for D-dimer, a significant amount of
the relationship between caregiver status and IL-6 was due
to age differences between these groups. In addition, the
interaction between age and caregiver status significantly
predicted D-dimer level and was of borderline significance
in predicting IL-6 level. Age was more strongly associated
with these two frailty markers in caregivers than in controls
independent of all medical and psychosocial covariates. We
conclude that psychosocial correlates of caregiving stress
other than general psychological distress and role overload
might act in the context of age to increase D-dimer level in
caregivers. For example, with increasing age, caregivers
might become particularly vulnerable to the stresses asso-
ciated with caregiving, particularly outcomes such as cardio-
vascular diseases. This assumption is partially supported by
a previous study showing a positive association between age
and covariate-adjusted 4-year mortality rates (5).
Although chronic stress has been associated with elevated
CRP level (37,38), we found no significant difference in
plasma levels of CRP between caregivers and controls. Given
that the absolute mean CRP value was relatively higher in
caregivers, a power issue could be involved. Also, our study
was not designed to assess and control for the many immu-
nological and molecular steps modulating the inflammatory
cascade leading from stress-related increase in IL-6 to
increased production and release of CRP by the liver (16).
IL-6 and D-dimer predict disease states which become
more prevalent in aging individuals. For instance, elevated
levels of IL-6 play an important pathogenetic role in
cardiovascular diseases, osteoporosis, Alzheimer’s disease,
and hematological neoplasia (10). Elevated D-dimer predicts
coronary events (12), recurrence of venous thromboembolic
events (39), and poor outcome in patients with cancer (40).
Therefore, our observation of increased levels of IL-6 and D-
dimer provides one biological pathway by which chronic
stress could hasten the development from clinically silent to
manifest organic diseases (and ultimately death) in aging
Alzheimer caregivers. Our observations further suggest that
older caregivers might be particularly vulnerable to experi-
ence accelerated health detoriation and transition to frailty. If
confirmed in a longitudinal study, our data may suggest that
there should be explorations of ways to attenuate caregiving
stress in elderly caregivers, particularly, for example, with
approaches such as enhancing respite availability, providing
practical assistance with caregiving, or modifying cognitive
and coping strategies aimed at lessening stress impact.
Our results need to be viewed within the context of several
possible limitations. First, there may be unreliability in the
health categorization (which were based on self report) of
our participants. Although previous studies showed good
agreement between medical charts and self-report of diseases
and drug intake (41,42), one might argue that health char-
acterization of individuals would be more accurate if
obtained from medical records. To the extent that the self-
report data created error, there would be no reason to ex-
pect it to be unevenly distributed between caregivers and
controls; such error variance would tend to lessen the
likelihood of finding meaningful relationships among the
variables of interest, thus introducing a conservative bias.
Second, in terms of generalizing from our results, it is
important to note that our participants were primarily
Caucasians of middle class economic status. Whether there
are effects of race, ethnicity, or more pervasive economic
stress on the relationships of caregiving to markers of frailty
will need to be determined through studies of larger and
more diverse populations. Third, although our sample size
allowed controlling for a reasonable set of modifiers of IL-6
and D-dimer levels, a very large sample size would be
required to control for all sorts of disease categories and
medication common in an elderly study population. There
were a number of insignificant differences in medical vari-
ables (e.g., frequency in use of statins or hormone replace-
ment therapy) which may not exert substantial effects
individually but, when aggregated and applied to a larger
sample, might account for some of the differences observed
between groups. Also, a more in-depth and costly medical
work-up would be required to track diseases such as occult
atherosclerosis (43), which may affect frailty markers. We
also found in a subset of the present sample that increased
apnea hypopnea index was related to greater IL-6 levels and
that more Stage 2 sleep was related to greater D-dimer levels,
specifically in the caregivers (44). Because we did not
investigate sleep in the present study, poor sleep could also
contribute to some of the relationship between caregiver
stress and increased IL-6 and D-dimer levels, respectively.
Conclusion
Alzheimer caregiver strain is related to markers of low-
grade systemic inflammation and coagulation activation,
which are also part of the frailty syndrome. Whereas care-
giving stress independently predicted D-dimer level, age was
a stronger predictor of D-dimer and IL-6 levels in caregivers
than in controls. Biological changes observed may help
explain accelerated health decline with, for example, pre-
mature manifestation of atherosclerotic diseases and mortal-
ity in Alzheimer caregivers, particularly in those of older age.
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